CCL2 and Alzheimer disease: However, in C. Manferdini et al, they found an opposite result, they showed that CM from AD-MSC cannot decrease a series of inflammation related cytokine including IL-6, CCL2/MCP-1, CCL3/MIP1-a and CCL5/RANTES [28].